Genscript Biotech (HK:1548) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Genscript Biotech Corporation has scheduled a board meeting for August 9, 2024, to discuss and potentially approve the interim financial results for the first half of the year, as well as to consider declaring an interim dividend. The meeting will involve the company’s directors and will address the performance of both the company and its subsidiaries. The announcement was made in both English and Chinese, with the English version taking precedence in case of discrepancies.
For further insights into HK:1548 stock, check out TipRanks’ Stock Analysis page.
